Version 5.4
Homo sapiens Protein: RARRES1
Summary
InnateDB Protein IDBP-63285.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol RARRES1
Protein Name retinoic acid receptor responder (tazarotene induced) 1
Synonyms LXNL; TIG1;
Species Homo sapiens
Ensembl Protein ENSP00000237696
InnateDB Gene IDBG-63283 (RARRES1)
Protein Structure
UniProt Annotation
Function Inhibitor of the cytoplasmic carboxypeptidase AGBL2, may regulate the alpha-tubulin tyrosination cycle. {ECO:0000269PubMed:21303978}.
Subcellular Localization Membrane {ECO:0000269PubMed:21303978}; Single-pass type III membrane protein {ECO:0000269PubMed:21303978}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
GO:0008285 negative regulation of cell proliferation
Cellular Component
GO:0016021 integral component of membrane
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID
InterPro IPR009684 Proteinase inhibitor I47, latexin
PFAM PF06907
PRINTS
PIRSF PIRSF011132
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P49788
PhosphoSite PhosphoSite-P49788
TrEMBL
UniProt Splice Variant
Entrez Gene 5918
UniGene Hs.708627
RefSeq NP_996846
HUGO HGNC:9867
OMIM 605090
CCDS CCDS3184
HPRD 05477
IMGT
EMBL BC029640 U27185
GenPept AAA99722 AAH29640

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca